BlackRock Health Sciences Opportunities Portfolio (SHSKX) is an MF managed by BlackRock / iShares. Its largest position is ELI LILLY & Co (LLY), representing 11.34% of fund assets.
BlackRock Health Sciences Opportunities Portfolio Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- SHSKX
- Type:
- MF
- Manager:
- BlackRock / iShares
- Total Assets:
- —
- Report Date:
- Feb 27, 2026
- Filing Date:
- Apr 24, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
11.34% | $740,960,740.58 | 704,342 |
|
-
JOHNSON & JOHNSON
|
10.22% | $667,862,070.33 | 2,688,331 |
|
-
AbbVie Inc.
|
4.11% | $268,679,016.00 | 1,157,700 |
|
-
GILEAD SCIENCES, INC.
|
3.96% | $258,640,056.90 | 1,736,422 |
|
-
Merck & Co., Inc.
|
3.55% | $231,767,018.92 | 1,871,806 |
|
-
AMGEN INC
|
3.49% | $228,299,409.28 | 588,158 |
|
-
UNITEDHEALTH GROUP INC
|
3.04% | $198,810,958.97 | 677,911 |
|
-
INTUITIVE SURGICAL INC
|
2.46% | $160,645,369.01 | 319,051 |
|
-
ABBOTT LABORATORIES
|
2.43% | $158,456,366.90 | 1,361,894 |
|
-
DANAHER CORP /DE/
|
2.31% | $150,858,682.88 | 716,192 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
2.28% | $148,665,387.46 | 285,286 |
|
-
Edwards Lifesciences Corp
|
2.26% | $147,948,008.25 | 1,710,975 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
2.08% | $135,792,581.94 | 273,318 |
|
-
Medtronic plc
|
2.00% | $130,504,913.54 | 1,336,319 |
|
-
STRYKER CORP
|
1.98% | $129,051,689.66 | 333,071 |
|
-
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
1.80% | $117,666,648.98 | 3,475,093 |
|
-
Cencora, Inc.
|
1.51% | $98,937,140.40 | 265,860 |
|
-
BOSTON SCIENTIFIC CORP
|
1.51% | $98,703,219.70 | 1,284,362 |
|
-
ASTRAZENECA PLC
|
1.45% | $94,646,702.97 | 449,772 |
|
-
ARGENX SE
|
1.42% | $93,058,072.80 | 121,340 |
|
-
MCKESSON CORP
|
1.20% | $78,655,868.94 | 79,662 |
|
-
ROGERS CORP
|
1.08% | $70,333,000.39 | 147,789 |
|
-
BIOGEN INC.
|
1.07% | $69,858,542.16 | 364,188 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.06% | $68,964,045.08 | 207,149 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
1.05% | $68,520,410.53 | 87,659 |
|
-
BRISTOL MYERS SQUIBB CO
|
1.05% | $68,425,129.08 | 1,097,084 |
|
-
HCA Healthcare, Inc.
|
1.02% | $66,585,938.50 | 125,705 |
|
-
BLACKROCK FUNDS III
|
0.88% | $57,464,138.82 | 57,435,421 |
|
-
EXACT SCIENCES CORPORATION
|
0.87% | $56,659,373.22 | 548,069 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
0.76% | $49,962,274.89 | 538,793 |
|
-
IDEXX LABORATORIES INC /DE
|
0.75% | $49,005,849.33 | 74,621 |
|
-
DEXCOM INC
|
0.75% | $48,740,557.67 | 663,769 |
|
-
Penumbra Inc
|
0.70% | $45,878,258.24 | 133,216 |
|
-
INSMED Inc
|
0.69% | $45,001,043.49 | 301,353 |
|
-
NOVARTIS AG
|
0.65% | $42,434,909.20 | 251,660 |
|
-
INCYTE CORP
|
0.61% | $40,120,540.98 | 396,174 |
|
-
Medline Inc.
|
0.61% | $40,030,643.23 | 842,573 |
|
-
WATERS CORP /DE/
|
0.61% | $39,746,521.62 | 124,449 |
|
-
BLACKROCK LIQUIDITY FUNDS T-FU
|
0.52% | $34,195,870.35 | 34,195,870 |
|
-
Protagonist Therapeutics, Inc
|
0.52% | $34,107,168.64 | 370,408 |
|
-
AGILENT TECHNOLOGIES, INC.
|
0.50% | $32,922,989.82 | 271,239 |
|
-
PFIZER INC
|
0.50% | $32,754,798.30 | 1,184,622 |
|
-
NUVALENT INC-A
|
0.49% | $32,199,989.95 | 315,841 |
|
-
Cogent Biosciences, Inc.
|
0.49% | $31,873,278.15 | 820,419 |
|
-
Guardant Health, Inc.
|
0.48% | $31,612,843.50 | 336,665 |
|
-
Revolution Medicines, Inc.
|
0.47% | $30,911,549.90 | 302,995 |
|
-
Moderna, Inc.
|
0.46% | $30,042,002.43 | 560,799 |
|
-
APPLIED MATERIALS INC /DE
|
0.44% | $28,935,096.50 | 153,331 |
|
-
CVS HEALTH Corp
|
0.44% | $28,706,631.80 | 359,282 |
|
-
Elevance Health, Inc.
|
0.43% | $28,353,600.00 | 88,605 |
Advertisement (320x50)